BRIEF-Keryx Biopharmaceuticals jumps in premarket after kidney disease drug meets trial goal

NEW YORK Mon Jan 28, 2013 7:32am EST

NEW YORK Jan 28 (Reuters) - Keryx Biopharmaceuticals Inc : * Keryx Biopharma jumps 46.4 percent to $5.02 in premarket after kidney disease drug meets late-stage trial goal

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.